SEER Cancer Statistics Review 1975-2015 National Cancer Institute Joinpoint Regression Program Version 4.6, February 2018, National Cancer Institute. (https://surveillance.cancer.gov/joinpoint/). The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130). a Trends are from the SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, and Atlanta). b Trends are from the SEER 13 areas (SEER 9 Areas, Los Angeles, San Jose-Monterey, Rural Georgia, and the Alaska Native Registry). c Trends are from US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention. d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint. e API - Asian/Pacific Islander, AI/AN - American Indian/Alaska Native, NH - Non-Hispanic f Hispanic and Non-Hispanic are not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registry. The Hispanic and Non-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma. g Data for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties. * The APC/AAPC is significantly different from zero (p<.05). - Joinpoint regression line analysis could not be performed on data series. JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPC d Years APC Years APC Years APC Years APC Years APC Years APC 2006-15 2011-15 SEER 9 Delay-Adjusted Incidence a , 1975-2015 All Races 1975-82 2.5* 1982-91 0.9* 1991-07 -0.7* 2007-15 -2.2* -2.0* -2.2* White 1975-82 2.6* 1982-91 1.1* 1991-07 -0.6* 2007-15 -2.1* -1.9* -2.1* Black 1975-84 3.5* 1984-03 -0.6* 2003-15 -2.3* -2.3* -2.3* SEER 13 Delay-Adjusted Incidence b , 1992-2015 All Races 1992-07 -1.0* 2007-15 -2.3* -2.2* -2.3* White 1992-07 -0.9* 2007-15 -2.3* -2.1* -2.3* Black 1992-08 -1.3* 2008-15 -3.2* -2.8* -3.2* SEER 9 Observed Incidence a , 1975-2015 All Races 1975-82 2.5* 1982-91 0.9* 1991-07 -0.7* 2007-15 -2.3* -2.1* -2.3* White 1975-82 2.6* 1982-91 1.1* 1991-07 -0.6* 2007-15 -2.3* -2.1* -2.3* Black 1975-85 3.2* 1985-08 -0.9* 2008-15 -3.5* -3.0* -3.5* SEER 13 Observed Incidence b , 1992-2015 All Races 1992-07 -1.0* 2007-15 -2.5* -2.3* -2.5* White 1992-07 -0.9* 2007-15 -2.5* -2.3* -2.5* White NH ef 1992-07 -0.7* 2007-15 -2.3* -2.2* -2.3* Black 1992-08 -1.3* 2008-15 -3.5* -3.0* -3.5* Black NH ef 1992-08 -1.2* 2008-15 -3.4* -2.9* -3.4* API e 1992-05 -0.4 2005-15 -1.5* -1.5* -1.5* AI/AN eg 1992-15 -1.2* -1.2* -1.2* Hispanic f 1992-15 -1.3* -1.3* -1.3* U.S. Cancer Mortality c , 1975-2015 All Races 1975-80 3.0* 1980-90 1.8* 1990-95 -0.2 1995-05 -1.0* 2005-12 -2.3* 2012-15 -3.4* -2.7* -3.1* White 1975-80 2.9* 1980-90 1.8* 1990-95 -0.1 1995-05 -0.8* 2005-10 -2.1* 2010-15 -2.9* -2.5* -2.9* Black 1975-81 3.5* 1981-90 1.9* 1990-95 -0.7* 1995-04 -1.7* 2004-13 -2.7* 2013-15 -5.0* -3.2* -3.8* U.S. Cancer Mortality c , 1992-2015 All Races 1992-04 -0.8* 2004-10 -2.1* 2010-15 -3.0* -2.6* -3.0* White 1992-03 -0.7* 2003-09 -1.7* 2009-15 -2.8* -2.4* -2.8* White NH ef 1992-03 -0.5* 2003-09 -1.5* 2009-15 -2.7* -2.3* -2.7* Black 1992-97 -1.1* 1997-04 -1.8* 2004-13 -2.6* 2013-15 -5.0* -3.2* -3.8* Black NH ef 1992-95 -0.6 1995-04 -1.7* 2004-13 -2.6* 2013-15 -5.0* -3.1* -3.8* API e 1992-08 -1.1* 2008-15 -1.8* -1.6* -1.8* AI/AN eg 1992-08 0.2 2008-15 -2.4* -1.8* -2.4* Hispanic f 1992-95 1.4 1995-04 -1.2* 2004-15 -2.4* -2.4* -2.4* Table 15.1 Cancer of the Lung and Bronchus (Invasive) Trends in SEER Incidence ab and U.S. Mortality c Using the Joinpoint Regression Program, 1975-2015 With up to Five Joinpoints, 1992-2015 With up to Four Joinpoints, Both Sexes by Race/Ethnicity
39
Embed
SEER Cancer Statistics Review 1975-2015 · b Trends are from the SEER 13 areas (SEER 9 Areas, Los Angeles, San Jose-Monterey, Rural Georgia, and the Alaska Native Registry). c Trends
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Joinpoint Regression Program Version 46 February 2018 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 13 areas (SEER 9 Areas Los Angeles San Jose-Monterey Rural Georgia and the Alaska Native Registry)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska
Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native RegistryThe Hispanic and Non-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
g Data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd Years APC Years APC Years APC Years APC Years APC Years APC 2006-15 2011-15
Table 151Cancer of the Lung and Bronchus (Invasive)
Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program1975-2015 With up to Five Joinpoints 1992-2015 With up to Four Joinpoints
Both Sexes by RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Joinpoint Regression Program Version 46 February 2018 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 13 areas (SEER 9 Areas Los Angeles San Jose-Monterey Rural Georgia and the Alaska Native Registry)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska
Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native RegistryThe Hispanic and Non-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
g Data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd Years APC Years APC Years APC Years APC Years APC Years APC 2006-15 2011-15
Table 152Cancer of the Lung and Bronchus (Invasive)
Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program1975-2015 With up to Five Joinpoints 1992-2015 With up to Four Joinpoints
Males by RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Joinpoint Regression Program Version 46 February 2018 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 13 areas (SEER 9 Areas Los Angeles San Jose-Monterey Rural Georgia and the Alaska Native Registry)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska
Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native RegistryThe Hispanic and Non-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
g Data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd Years APC Years APC Years APC Years APC Years APC Years APC 2006-15 2011-15
Table 153Cancer of the Lung and Bronchus (Invasive)
Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program1975-2015 With up to Five Joinpoints 1992-2015 With up to Four Joinpoints
Females by RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Joinpoint Regression Program Version 46 February 2018 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-8052
c Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd Years APC Years APC Years APC Years APC Years APC Years APC 2011-15
SEER 9 Observed Incidencec for Small Cell Cancer of the Lung and Bronchusa 1975-2015
All Races Both Sexes 1975-82 62 1982-89 13 1989-15 -24 -24All Races Male 1975-81 56 1981-88 00 1988-15 -31 -31All Races Female 1975-82 96 1982-91 31 1991-15 -19 -19
White Both Sexes 1975-82 63 1982-89 15 1989-15 -23 -23White Male 1975-78 89 1978-86 20 1986-15 -30 -30White Female 1975-82 102 1982-91 32 1991-15 -17 -17
Black Both Sexes 1975-86 49 1986-15 -25 -25Black Male 1975-85 50 1985-15 -34 -34Black Female 1975-91 46 1991-15 -19 -19
SEER 9 Observed Incidencec for Non-Small Cell Cancer of the Lung and Bronchusb 1975-2015
Table 154Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
Trends in SEER 9 Observed Incidencec Using the Joinpoint Regression Program1975-2015 With up to Five Joinpoints
By Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 155Cancer of the Lung and Bronchus (Invasive)
Delay-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 156Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2011-2015All ages 62 68 58 68 72 66 56 68 48Under 65 22 22 22 25 24 25 22 24 2065 and over 341 385 309 370 404 346 296 372 247
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
d Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Joinpoint Regression Program Version 46 February 2018 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 13 areas (SEER 9 Areas Los Angeles San Jose-Monterey Rural Georgia and the Alaska Native Registry)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska
Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native RegistryThe Hispanic and Non-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
g Data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd Years APC Years APC Years APC Years APC Years APC Years APC 2006-15 2011-15
Table 152Cancer of the Lung and Bronchus (Invasive)
Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program1975-2015 With up to Five Joinpoints 1992-2015 With up to Four Joinpoints
Males by RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Joinpoint Regression Program Version 46 February 2018 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 13 areas (SEER 9 Areas Los Angeles San Jose-Monterey Rural Georgia and the Alaska Native Registry)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska
Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native RegistryThe Hispanic and Non-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
g Data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd Years APC Years APC Years APC Years APC Years APC Years APC 2006-15 2011-15
Table 153Cancer of the Lung and Bronchus (Invasive)
Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program1975-2015 With up to Five Joinpoints 1992-2015 With up to Four Joinpoints
Females by RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Joinpoint Regression Program Version 46 February 2018 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-8052
c Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd Years APC Years APC Years APC Years APC Years APC Years APC 2011-15
SEER 9 Observed Incidencec for Small Cell Cancer of the Lung and Bronchusa 1975-2015
All Races Both Sexes 1975-82 62 1982-89 13 1989-15 -24 -24All Races Male 1975-81 56 1981-88 00 1988-15 -31 -31All Races Female 1975-82 96 1982-91 31 1991-15 -19 -19
White Both Sexes 1975-82 63 1982-89 15 1989-15 -23 -23White Male 1975-78 89 1978-86 20 1986-15 -30 -30White Female 1975-82 102 1982-91 32 1991-15 -17 -17
Black Both Sexes 1975-86 49 1986-15 -25 -25Black Male 1975-85 50 1985-15 -34 -34Black Female 1975-91 46 1991-15 -19 -19
SEER 9 Observed Incidencec for Non-Small Cell Cancer of the Lung and Bronchusb 1975-2015
Table 154Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
Trends in SEER 9 Observed Incidencec Using the Joinpoint Regression Program1975-2015 With up to Five Joinpoints
By Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 155Cancer of the Lung and Bronchus (Invasive)
Delay-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 156Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2011-2015All ages 62 68 58 68 72 66 56 68 48Under 65 22 22 22 25 24 25 22 24 2065 and over 341 385 309 370 404 346 296 372 247
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
d Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Joinpoint Regression Program Version 46 February 2018 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 13 areas (SEER 9 Areas Los Angeles San Jose-Monterey Rural Georgia and the Alaska Native Registry)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska
Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native RegistryThe Hispanic and Non-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
g Data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd Years APC Years APC Years APC Years APC Years APC Years APC 2006-15 2011-15
Table 153Cancer of the Lung and Bronchus (Invasive)
Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program1975-2015 With up to Five Joinpoints 1992-2015 With up to Four Joinpoints
Females by RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Joinpoint Regression Program Version 46 February 2018 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-8052
c Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd Years APC Years APC Years APC Years APC Years APC Years APC 2011-15
SEER 9 Observed Incidencec for Small Cell Cancer of the Lung and Bronchusa 1975-2015
All Races Both Sexes 1975-82 62 1982-89 13 1989-15 -24 -24All Races Male 1975-81 56 1981-88 00 1988-15 -31 -31All Races Female 1975-82 96 1982-91 31 1991-15 -19 -19
White Both Sexes 1975-82 63 1982-89 15 1989-15 -23 -23White Male 1975-78 89 1978-86 20 1986-15 -30 -30White Female 1975-82 102 1982-91 32 1991-15 -17 -17
Black Both Sexes 1975-86 49 1986-15 -25 -25Black Male 1975-85 50 1985-15 -34 -34Black Female 1975-91 46 1991-15 -19 -19
SEER 9 Observed Incidencec for Non-Small Cell Cancer of the Lung and Bronchusb 1975-2015
Table 154Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
Trends in SEER 9 Observed Incidencec Using the Joinpoint Regression Program1975-2015 With up to Five Joinpoints
By Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 155Cancer of the Lung and Bronchus (Invasive)
Delay-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 156Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2011-2015All ages 62 68 58 68 72 66 56 68 48Under 65 22 22 22 25 24 25 22 24 2065 and over 341 385 309 370 404 346 296 372 247
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
d Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Joinpoint Regression Program Version 46 February 2018 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-8052
c Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPCd Years APC Years APC Years APC Years APC Years APC Years APC 2011-15
SEER 9 Observed Incidencec for Small Cell Cancer of the Lung and Bronchusa 1975-2015
All Races Both Sexes 1975-82 62 1982-89 13 1989-15 -24 -24All Races Male 1975-81 56 1981-88 00 1988-15 -31 -31All Races Female 1975-82 96 1982-91 31 1991-15 -19 -19
White Both Sexes 1975-82 63 1982-89 15 1989-15 -23 -23White Male 1975-78 89 1978-86 20 1986-15 -30 -30White Female 1975-82 102 1982-91 32 1991-15 -17 -17
Black Both Sexes 1975-86 49 1986-15 -25 -25Black Male 1975-85 50 1985-15 -34 -34Black Female 1975-91 46 1991-15 -19 -19
SEER 9 Observed Incidencec for Non-Small Cell Cancer of the Lung and Bronchusb 1975-2015
Table 154Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
Trends in SEER 9 Observed Incidencec Using the Joinpoint Regression Program1975-2015 With up to Five Joinpoints
By Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 155Cancer of the Lung and Bronchus (Invasive)
Delay-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 156Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2011-2015All ages 62 68 58 68 72 66 56 68 48Under 65 22 22 22 25 24 25 22 24 2065 and over 341 385 309 370 404 346 296 372 247
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
d Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 155Cancer of the Lung and Bronchus (Invasive)
Delay-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 156Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2011-2015All ages 62 68 58 68 72 66 56 68 48Under 65 22 22 22 25 24 25 22 24 2065 and over 341 385 309 370 404 346 296 372 247
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
d Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 156Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2011-2015All ages 62 68 58 68 72 66 56 68 48Under 65 22 22 22 25 24 25 22 24 2065 and over 341 385 309 370 404 346 296 372 247
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
d Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2011-2015All ages 62 68 58 68 72 66 56 68 48Under 65 22 22 22 25 24 25 22 24 2065 and over 341 385 309 370 404 346 296 372 247
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
d Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2011-2015All ages 62 68 58 68 72 66 56 68 48Under 65 22 22 22 25 24 25 22 24 2065 and over 341 385 309 370 404 346 296 372 247
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
d Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2011-2015All ages 62 68 58 68 72 66 56 68 48Under 65 22 22 22 25 24 25 22 24 2065 and over 341 385 309 370 404 346 296 372 247
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
d Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2011-2015All ages 62 68 58 68 72 66 56 68 48Under 65 22 22 22 25 24 25 22 24 2065 and over 341 385 309 370 404 346 296 372 247
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
d Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 18 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2011-2015All ages 62 68 58 68 72 66 56 68 48Under 65 22 22 22 25 24 25 22 24 2065 and over 341 385 309 370 404 346 296 372 247
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
d Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
d Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2015 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2015
c Period survival provides a 2014 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2008-2014 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 624 515 Asian 0 000 000 001 545 417
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 668 574 Asian 0 000 000 000 659 512
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2013-2015 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Devcan 676 April 2018 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jerseyand Georgia excluding ATLRG) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area)counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 587 462 Asian 0 000 000 001 452 342
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2013-2015 By RaceEthnicity
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 46 February 2018 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG
c The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 4 Joinpoints overdiagnosis years 1992-2015
d The 2006-2015 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2015
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry The 2006-2015 Hispanic andNon-Hispanic mortality trends exclude deaths from New Hampshire and Oklahoma
f Incidence data for American IndianAlaska Native are based on the CHSDA(Contract Health ServiceDelivery Area) counties
g US Mortality Files National Center for Health Statistics CDCh The 2006-2015 mortality AAPCs are based on a Joinpoint analysis using years of death 1992-2015 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4337 5383 3539 4413 5386 3664 4621 6509 3351
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4337 005
High Five StatesKentucky 6772 052 01(0101) 5615c
Arkansas 5904 058 02(0205) 3612c
West Virginia 5880 069 03(0205) 3557c
Mississippi 5742 059 04(0205) 3239c
Tennessee 5697 039 05(0305) 3136c
Low Five StatesCalifornia 3216 013 47(4748) -2585c
Hawaii 3160 062 48(4750) -2715c
New Mexico 3063 051 49(4850) -2938c
Colorado 3020 035 50(4850) -3038c
Utah 1949 042 51(5151) -5507c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males and Females
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5383 008
High Five StatesKentucky 8667 090 01(0101) 6099c
Mississippi 8030 108 02(0203) 4916c
Arkansas 7852 101 03(0205) 4586c
West Virginia 7574 119 04(0307) 4069c
Tennessee 7510 069 05(0306) 3950c
Low Five StatesWyoming 3982 170 47(4249) -2603c
California 3832 022 48(4649) -2882c
New Mexico 3628 084 49(4750) -3261c
Colorado 3396 056 50(4950) -3691c
Utah 2389 069 51(5151) -5562c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Males
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3539 006
High Five StatesKentucky 5349 062 01(0101) 5113c
West Virginia 4573 084 02(0204) 2920c
Oklahoma 4463 062 03(0209) 2610c
Missouri 4403 048 04(0208) 2440c
Arkansas 4373 068 05(0213) 2355c
Low Five StatesCalifornia 2750 016 47(4648) -2231c
Colorado 2734 045 48(4649) -2277c
New Mexico 2618 064 49(4850) -2604c
Hawaii 2503 075 50(4950) -2930c
Utah 1585 051 51(5151) -5521c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2011-2015
Females
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 112015US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 4023 years
b c d Statistics based on (b) SEER 9 Areas (c) SEER 13 Areas excluding the Alaska Native Registry(d) NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry
e Maximum limited-duration prevalence 40 years for 1975-2015 SEER 9 data 23 years for 1992-2015 SEER 13 data(excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsg h i (g) Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000) (h) Complete prevalence is obtained by summing 0 to lt40 and gt=40 (i) Age-specific completeness indexwas approximated using empirical data from historical Connecticut tumor registry
- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt25 25 to lt30 0 to lt23e 0 to lt40e gt=40g Completeh
Race Sex All Racesb Both Sexes 314786 112172 51962 27782 14327 7630 521029 534600 6435 541035
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2015By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2015 of the SEERc population diagnosed in the previous 23 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Males by Race
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2011-2015Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
0
30
60
90
120
150
180
1975 1985 1995 2005 20150
30
60
90
120
150
180
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
0
20
40
60
80
100
1975 1985 1995 2005 20150
20
40
60
80
100
1975 1985 1995 2005 20150
20
40
60
80
100
1975 1985 1995 2005 20150
20
40
60
80
100
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
0
100
200
300
400
500
600
700
800
1975 1985 1995 2005 20150
100
200
300
400
500
600
700
800
1975 1985 1995 2005 20150
100
200
300
400
1975 1985 1995 2005 20150
100
200
300
400
1975 1985 1995 2005 2015
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
Joinpoint Analyses for Whites and Blacks from 1975-2015and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 1992-2015
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20150
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2015
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 13 Areas (SEER 9 Areas San Jose-MontereyLos Angeles Alaska Native Registry and Rural Georgia) Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2015 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 1992-2015 allow a maximum of 4 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the CHSDA(Contract Health Service Delivery Area) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry Mortality data for Hispanics exclude cases from New Hampshire and Oklahoma
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2015N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2015
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2015 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2015
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2015
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 46 February 2018National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Male by Race
aFigure 157
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
SEER Observed Incidence and SEER Delay Adjusted Incidence RatesSEER 9 Areas Compared to SEER 13 Areas
Cancer of the Lung and Bronchus Female by Race
aFigure 158
Source SEER 9 areas and SEER 13 areasRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 46 February 2018 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
All Races White BlackRate per 100000 Rate per 100000 Rate per 100000
Year of Diagnosis Year of Diagnosis Year of Diagnosis
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females
Graph - 5-Year SEER Conditional Relative Survival
Figure 159
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG) California excluding SFSJMLA KentuckyLouisiana New Jersey and Georgia excluding ATLRG contribute cases for diagnosis years 2000 and laterThe remaining 13 SEER Areas contribute cases for the entire time periodPercent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
1998-2014 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2015 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying
Risk of DevelopingDying
Risk of DevelopingDying
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Males
Graph - SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas Females